Abstract:To investigate the regulatory effects of Sanghuangporus vaninii polysaccharides (SVP) and Sanghuangporus sanghuang polysaccharides (SSP) on the intestinal microbiota in normal organism (including human beings), normal mice were applied as experimental animals in the work to conduct a systematic analysis on the intestinal flora through animal feeding experiments combined with high-throughput sequencing of microorganisms. Thirty mice were randomly divided into control group, SVP group, and SSP group, with the latter two groups being further subdivided into low-dose and high-dose subgroups (administered 200 and 400 mg·kg-1·d via gavage, respectively). It was demonstrated that SVP and SSP had no significant effects on the growth status, body weight and thymus coefficient of mice, but could significantly reduce the spleen coefficient (P<0.05). The results from high-throughput sequencing analysis on microorganisms in mice feces revealed that both SSP and SVP could significantly reduce the ratio of Firmicutes to Bacteroidetes in the intestinal tract (both decreased by more than 55% compared with CK14). The abundance of the Alistipes was significantly increased by SSP (compared with CK14, increased by 59.25% and 65.62% in SL14 and SH14, respectively). The abundance enhancement of Verrucomicrobia and Muribaculum was detected in both SVP and SSP treated groups, suggesting the potential resistance to metabolic diseases mediated by SVP and SSP. Heatmap and hierarchical clustering analysis demonstrated that the primary factor influencing the intestinal microbiota of mice was identified as the dosage rather than the type of Sanghuangporus spp. polysaccharides. It was concluded that both SVP and SSP could have beneficial effects on the intestinal flora, and thereby provide a theoretical foundation for the application of Sanghuangporus spp. in functional foods and health-care products.